🇺🇸 FDA
Patent

US 9447100

Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents

granted A61PA61P13/12A61P19/00

Quick answer

US patent 9447100 (Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents) held by Takeda Pharmaceutical Company Limited expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P13/12, A61P19/00, A61P19/02, A61P19/08